SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Affimed Announces Participation at Upcoming Virtual Investor Conferences
[March 26, 2020]

Affimed Announces Participation at Upcoming Virtual Investor Conferences


Heidelberg, Germany, March 26, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that the company will participate in the following upcoming virtual investor conferences.

  • Dr. Adi Hoess, Chief Executive Officer, will present at the Solebury Trout Virtual Global Healthcare Conference Series on Thursday, April 2, 2020 at 9:30 a.m. Eastern Time. The presentation will be webcast live and available for replay in the investor relations section of Affimed’s website at https://www.ffimed.com/investors/webcasts_cp/.  
  • Dr. Adi Hoess will conduct virtual one-on-one meetings with institutional investors at the 2020 Wells Fargo Biotech Corporate Access Day on Tuesday, April 7, 2020.



About Affimed N.V.

Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer. Affimed’s fit-for-purpose ROCK® platform allows innate cell engagers to be designed for specific patient populations. The Company is developing single and combination therapies to treat hematologic and solid tumors. For more information, please visit www.affimed.com.  


Affimed Investor and Media Contacts

Gregory Gin, Head of Investor Relations
E-Mail: IR@affimed.com

Primary Logo


[ Back To TMCnet.com's Homepage ]









Technology Marketing Corporation

2 Trap Falls Road Suite 106, Shelton, CT 06484 USA
Ph: +1-203-852-6800, 800-243-6002

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2020 Technology Marketing Corporation. All rights reserved | Privacy Policy